Open Access

[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin

  • Authors:
    • Hang Tian
    • Lei Hou
    • Yu-Mei Xiong
    • Jun-Xiang Huang
    • Ying-Jun She
    • Xiao-Bao Bi
    • Xing-Rong Song
  • View Affiliations

  • Published online on: January 17, 2022     https://doi.org/10.3892/or.2022.8265
  • Article Number: 54
  • Copyright : © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 33: [Related article:] 981-989, 2015; DOI: 10.3892/or.2014.3657

Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that certain of the western blotting data shown in Fig. 6 and the tumor images shown in Fig. 7A were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

March-2022
Volume 47 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tian H, Hou L, Xiong Y, Huang J, She Y, Bi X and Song X: [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Oncol Rep 47: 54, 2022
APA
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., & Song, X. (2022). [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Oncology Reports, 47, 54. https://doi.org/10.3892/or.2022.8265
MLA
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., Song, X."[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin". Oncology Reports 47.3 (2022): 54.
Chicago
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., Song, X."[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin". Oncology Reports 47, no. 3 (2022): 54. https://doi.org/10.3892/or.2022.8265